Herein, we report the outcomes and characteristics of patients and breast cancers, including RS, in a large cohort of patients with BRCAm and BRCAwt early‐stage HR+, HER2‐negative breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.